 | • レポートコード：D0GIR-02437 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウイルス不活化の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルス不活化の種類別市場規模（キット・試薬、サービス、ウイルス不活化システム・付属品）、用途別市場規模（血液および血液製剤、細胞および遺伝子治療製品、幹細胞製品、組織および組織製品、ワクチンおよび治療薬）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Danaher、Rad Source Technologies、Sartorius、Merck、Clean Cells、Parker Hannifin、Viral Inactivated Plasma Systems、Charles River Laboratories International、SGS、Texcell、Wuxi Pharmatech (Cayman) ・地域別グローバル市場分析 2015年-2020年 ・ウイルス不活化の北米市場（アメリカ、カナダ、メキシコ） ・ウイルス不活化のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウイルス不活化のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウイルス不活化の南米市場（ブラジル、アルゼンチン） ・ウイルス不活化の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：キット・試薬、サービス、ウイルス不活化システム・付属品 ・用途別分析：血液および血液製剤、細胞および遺伝子治療製品、幹細胞製品、組織および組織製品、ワクチンおよび治療薬 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Viral Inactivation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 487.1 million by 2025, from USD 376.2 million in 2019.
The Viral Inactivation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Viral Inactivation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Viral Inactivation market has been segmented into:
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
By Application, Viral Inactivation has been segmented into:
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Inactivation market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Inactivation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Inactivation market.
The report offers in-depth assessment of the growth and other aspects of the Viral Inactivation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Viral Inactivation Market Share Analysis
Viral Inactivation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Inactivation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Inactivation sales, revenue and market share for each player covered in this report.
The major players covered in Viral Inactivation are:
Danaher
Rad Source Technologies
Sartorius
Merck
Clean Cells
Parker Hannifin
Viral Inactivated Plasma Systems
Charles River Laboratories International
SGS
Texcell
Wuxi Pharmatech (Cayman)
Table of Contents
1 Viral Inactivation Market Overview
1.1 Product Overview and Scope of Viral Inactivation
1.2 Classification of Viral Inactivation by Type
1.2.1 Global Viral Inactivation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Inactivation Revenue Market Share by Type in 2019
1.2.3 Kits and Reagents
1.2.4 Services
1.2.5 Viral Inactivation Systems and Accessories
1.3 Global Viral Inactivation Market by Application
1.3.1 Overview: Global Viral Inactivation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Global Viral Inactivation Market by Regions
1.4.1 Global Viral Inactivation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Inactivation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Inactivation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Inactivation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Inactivation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Inactivation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Inactivation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Danaher SWOT Analysis
2.1.4 Danaher Product and Services
2.1.5 Danaher Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Rad Source Technologies
2.2.1 Rad Source Technologies Details
2.2.2 Rad Source Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Rad Source Technologies SWOT Analysis
2.2.4 Rad Source Technologies Product and Services
2.2.5 Rad Source Technologies Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sartorius
2.3.1 Sartorius Details
2.3.2 Sartorius Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sartorius SWOT Analysis
2.3.4 Sartorius Product and Services
2.3.5 Sartorius Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Clean Cells
2.5.1 Clean Cells Details
2.5.2 Clean Cells Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Clean Cells SWOT Analysis
2.5.4 Clean Cells Product and Services
2.5.5 Clean Cells Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Parker Hannifin
2.6.1 Parker Hannifin Details
2.6.2 Parker Hannifin Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Parker Hannifin SWOT Analysis
2.6.4 Parker Hannifin Product and Services
2.6.5 Parker Hannifin Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.7 Viral Inactivated Plasma Systems
2.7.1 Viral Inactivated Plasma Systems Details
2.7.2 Viral Inactivated Plasma Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Viral Inactivated Plasma Systems SWOT Analysis
2.7.4 Viral Inactivated Plasma Systems Product and Services
2.7.5 Viral Inactivated Plasma Systems Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Charles River Laboratories International
2.8.1 Charles River Laboratories International Details
2.8.2 Charles River Laboratories International Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Charles River Laboratories International SWOT Analysis
2.8.4 Charles River Laboratories International Product and Services
2.8.5 Charles River Laboratories International Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.9 SGS
2.9.1 SGS Details
2.9.2 SGS Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 SGS SWOT Analysis
2.9.4 SGS Product and Services
2.9.5 SGS Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Texcell
2.10.1 Texcell Details
2.10.2 Texcell Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Texcell SWOT Analysis
2.10.4 Texcell Product and Services
2.10.5 Texcell Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wuxi Pharmatech (Cayman)
2.11.1 Wuxi Pharmatech (Cayman) Details
2.11.2 Wuxi Pharmatech (Cayman) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wuxi Pharmatech (Cayman) SWOT Analysis
2.11.4 Wuxi Pharmatech (Cayman) Product and Services
2.11.5 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Inactivation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Inactivation Players Market Share
3.2.2 Top 10 Viral Inactivation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Inactivation Revenue and Market Share by Regions
4.2 North America Viral Inactivation Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Inactivation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Inactivation Revenue and Growth Rate (2015-2020)
4.5 South America Viral Inactivation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Inactivation Revenue and Growth Rate (2015-2020)
5 North America Viral Inactivation Revenue by Countries
5.1 North America Viral Inactivation Revenue by Countries (2015-2020)
5.2 USA Viral Inactivation Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Inactivation Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Inactivation Revenue and Growth Rate (2015-2020)
6 Europe Viral Inactivation Revenue by Countries
6.1 Europe Viral Inactivation Revenue by Countries (2015-2020)
6.2 Germany Viral Inactivation Revenue and Growth Rate (2015-2020)
6.3 UK Viral Inactivation Revenue and Growth Rate (2015-2020)
6.4 France Viral Inactivation Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Inactivation Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Inactivation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Inactivation Revenue by Countries
7.1 Asia-Pacific Viral Inactivation Revenue by Countries (2015-2020)
7.2 China Viral Inactivation Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Inactivation Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Inactivation Revenue and Growth Rate (2015-2020)
7.5 India Viral Inactivation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Inactivation Revenue and Growth Rate (2015-2020)
8 South America Viral Inactivation Revenue by Countries
8.1 South America Viral Inactivation Revenue by Countries (2015-2020)
8.2 Brazil Viral Inactivation Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Inactivation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Inactivation by Countries
9.1 Middle East & Africa Viral Inactivation Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Inactivation Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Inactivation Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Inactivation Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Inactivation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Inactivation Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Inactivation Market Forecast by Type (2019-2024)
10.3 Kits and Reagents Revenue Growth Rate (2015-2025)
10.4 Services Revenue Growth Rate (2015-2025)
10.5 Viral Inactivation Systems and Accessories Revenue Growth Rate (2015-2025)
11 Global Viral Inactivation Market Segment by Application
11.1 Global Viral Inactivation Revenue Market Share by Application (2015-2020)
11.2 Viral Inactivation Market Forecast by Application (2019-2024)
11.3 Blood and Blood Products Revenue Growth (2015-2020)
11.4 Cellular and Gene Therapy Products Revenue Growth (2015-2020)
11.5 Stem Cell Products Revenue Growth (2015-2020)
11.6 Tissue and Tissue Products Revenue Growth (2015-2020)
11.7 Vaccines and Therapeutics Revenue Growth (2015-2020)
12 Global Viral Inactivation Market Size Forecast (2021-2025)
12.1 Global Viral Inactivation Market Size Forecast (2021-2025)
12.2 Global Viral Inactivation Market Forecast by Regions (2021-2025)
12.3 North America Viral Inactivation Revenue Market Forecast (2021-2025)
12.4 Europe Viral Inactivation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Inactivation Revenue Market Forecast (2021-2025)
12.6 South America Viral Inactivation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Inactivation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Viral Inactivation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Inactivation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Inactivation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Inactivation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Danaher Corporate Information, Location and Competitors
Table 6. Danaher Viral Inactivation Major Business
Table 7. Danaher Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 8. Danaher SWOT Analysis
Table 9. Danaher Viral Inactivation Product and Solutions
Table 10. Danaher Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Rad Source Technologies Corporate Information, Location and Competitors
Table 12. Rad Source Technologies Viral Inactivation Major Business
Table 13. Rad Source Technologies Viral Inactivation Total Revenue (USD Million) (2018-2019)
Table 14. Rad Source Technologies SWOT Analysis
Table 15. Rad Source Technologies Viral Inactivation Product and Solutions
Table 16. Rad Source Technologies Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sartorius Corporate Information, Location and Competitors
Table 18. Sartorius Viral Inactivation Major Business
Table 19. Sartorius Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 20. Sartorius SWOT Analysis
Table 21. Sartorius Viral Inactivation Product and Solutions
Table 22. Sartorius Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Viral Inactivation Major Business
Table 25. Merck Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Viral Inactivation Product and Solutions
Table 28. Merck Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Clean Cells Corporate Information, Location and Competitors
Table 30. Clean Cells Viral Inactivation Major Business
Table 31. Clean Cells Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 32. Clean Cells SWOT Analysis
Table 33. Clean Cells Viral Inactivation Product and Solutions
Table 34. Clean Cells Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Parker Hannifin Corporate Information, Location and Competitors
Table 36. Parker Hannifin Viral Inactivation Major Business
Table 37. Parker Hannifin Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 38. Parker Hannifin SWOT Analysis
Table 39. Parker Hannifin Viral Inactivation Product and Solutions
Table 40. Parker Hannifin Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Viral Inactivated Plasma Systems Corporate Information, Location and Competitors
Table 42. Viral Inactivated Plasma Systems Viral Inactivation Major Business
Table 43. Viral Inactivated Plasma Systems Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 44. Viral Inactivated Plasma Systems SWOT Analysis
Table 45. Viral Inactivated Plasma Systems Viral Inactivation Product and Solutions
Table 46. Viral Inactivated Plasma Systems Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Charles River Laboratories International Corporate Information, Location and Competitors
Table 48. Charles River Laboratories International Viral Inactivation Major Business
Table 49. Charles River Laboratories International Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 50. Charles River Laboratories International SWOT Analysis
Table 51. Charles River Laboratories International Viral Inactivation Product and Solutions
Table 52. Charles River Laboratories International Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. SGS Corporate Information, Location and Competitors
Table 54. SGS Viral Inactivation Major Business
Table 55. SGS Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 56. SGS SWOT Analysis
Table 57. SGS Viral Inactivation Product and Solutions
Table 58. SGS Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Texcell Corporate Information, Location and Competitors
Table 60. Texcell Viral Inactivation Major Business
Table 61. Texcell Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 62. Texcell SWOT Analysis
Table 63. Texcell Viral Inactivation Product and Solutions
Table 64. Texcell Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Wuxi Pharmatech (Cayman) Corporate Information, Location and Competitors
Table 66. Wuxi Pharmatech (Cayman) Viral Inactivation Major Business
Table 67. Wuxi Pharmatech (Cayman) Viral Inactivation Total Revenue (USD Million) (2017-2018)
Table 68. Wuxi Pharmatech (Cayman) SWOT Analysis
Table 69. Wuxi Pharmatech (Cayman) Viral Inactivation Product and Solutions
Table 70. Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Viral Inactivation Revenue (Million USD) by Players (2015-2020)
Table 72. Global Viral Inactivation Revenue Share by Players (2015-2020)
Table 73. Global Viral Inactivation Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Viral Inactivation Revenue Market Share by Regions (2015-2020)
Table 75. North America Viral Inactivation Revenue by Countries (2015-2020)
Table 76. North America Viral Inactivation Revenue Market Share by Countries (2015-2020)
Table 77. Europe Viral Inactivation Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Viral Inactivation Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Viral Inactivation Revenue by Countries (2015-2020)
Table 80. South America Viral Inactivation Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Viral Inactivation Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Viral Inactivation Revenue Market Share by Countries (2015-2020)
Table 83. Global Viral Inactivation Revenue (Million USD) by Type (2015-2020)
Table 84. Global Viral Inactivation Revenue Share by Type (2015-2020)
Table 85. Global Viral Inactivation Revenue Forecast by Type (2021-2025)
Table 86. Global Viral Inactivation Revenue by Application (2015-2020)
Table 87. Global Viral Inactivation Revenue Share by Application (2015-2020)
Table 88. Global Viral Inactivation Revenue Forecast by Application (2021-2025)
Table 89. Global Viral Inactivation Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Inactivation Picture
Figure 2. Global Viral Inactivation Revenue Market Share by Type in 2019
Figure 3. Kits and Reagents Picture
Figure 4. Services Picture
Figure 5. Viral Inactivation Systems and Accessories Picture
Figure 6. Viral Inactivation Revenue Market Share by Application in 2019
Figure 7. Blood and Blood Products Picture
Figure 8. Cellular and Gene Therapy Products Picture
Figure 9. Stem Cell Products Picture
Figure 10. Tissue and Tissue Products Picture
Figure 11. Vaccines and Therapeutics Picture
Figure 12. Global Viral Inactivation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Viral Inactivation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Viral Inactivation Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Viral Inactivation Revenue Market Share in 2019
Figure 21. Global Top 10 Players Viral Inactivation Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Viral Inactivation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Viral Inactivation Revenue Market Share by Regions (2015-2020)
Figure 25. Global Viral Inactivation Revenue Market Share by Regions in 2018
Figure 26. North America Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 27. Europe Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 29. South America Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 31. North America Viral Inactivation Revenue Market Share by Countries (2015-2020)
Figure 32. North America Viral Inactivation Revenue Market Share by Countries in 2019
Figure 33. USA Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 34. Canada Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 36. Europe Viral Inactivation Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Viral Inactivation Revenue Market Share by Countries in 2019
Figure 38. Germany Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 39. UK Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 40. France Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 41. Russia Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 42. Italy Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Viral Inactivation Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Viral Inactivation Revenue Market Share by Countries in 2019
Figure 45. China Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 46. Japan Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 47. Korea Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 48. India Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 50. South America Viral Inactivation Revenue Market Share by Countries (2015-2020)
Figure 51. South America Viral Inactivation Revenue Market Share by Countries in 2019
Figure 52. Brazil Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Viral Inactivation Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Viral Inactivation Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 57. UAE Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Viral Inactivation Revenue and Growth Rate (2015-2020)
Figure 60. Global Viral Inactivation Revenue Share by Type (2015-2020)
Figure 61. Global Viral Inactivation Revenue Share by Type in 2019
Figure 62. Global Viral Inactivation Market Share Forecast by Type (2021-2025)
Figure 63. Global Kits and Reagents Revenue Growth Rate (2015-2020)
Figure 64. Global Services Revenue Growth Rate (2015-2020)
Figure 65. Global Viral Inactivation Systems and Accessories Revenue Growth Rate (2015-2020)
Figure 66. Global Viral Inactivation Revenue Share by Application (2015-2020)
Figure 67. Global Viral Inactivation Revenue Share by Application in 2019
Figure 68. Global Viral Inactivation Market Share Forecast by Application (2021-2025)
Figure 69. Global Blood and Blood Products Revenue Growth Rate (2015-2020)
Figure 70. Global Cellular and Gene Therapy Products Revenue Growth Rate (2015-2020)
Figure 71. Global Stem Cell Products Revenue Growth Rate (2015-2020)
Figure 72. Global Tissue and Tissue Products Revenue Growth Rate (2015-2020)
Figure 73. Global Vaccines and Therapeutics Revenue Growth Rate (2015-2020)
Figure 74. Global Viral Inactivation Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Viral Inactivation Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Viral Inactivation Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Viral Inactivation Revenue Market Forecast (2021-2025)
Figure 78. Europe Viral Inactivation Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Viral Inactivation Revenue Market Forecast (2021-2025)
Figure 80. South America Viral Inactivation Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Viral Inactivation Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
ウイルスクリアランスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Clearance market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 338.5 million by 2025, from USD 223.8 million in 2019. The Viral Clearance marke…- ウイルス性結膜炎薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Conjunctivitis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Viral Conjunctivit…
- ウイルス分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10750 million by 2025, from USD 8231.6 million in 2019. The Viral Mol…
- ウイルス輸送媒体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Viral Transport Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 節足動物媒介ウイルス感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Arthropod-borne Viral Infections Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …